Healer's Art: Integrating the Humanities Into Medical Education Oct. 23, 2020 A collaboration between the UA College of Medicine – Tucson and the College of Humanities is focusing on teaching medical students empathy and compassion. Arizona Daily Wildcat
Pima County Braces for Rise in COVID-19 Cases as Arizona Continues to See Increase Oct. 23, 2020 Positive COVID-19 cases are on the rise in Pima County. "Given the possibility of exponential growth, current conditions could deteriorate rapidly," said Joe Gerald, an associate professor at University of Arizona's Mel and Enid Zuckerman College of Public Health. KGUN-TV (ABC) Tucson
A Second Pathway Into Cells for SARS-CoV-2: New Understanding of the Neuropilin-1 Protein Could Speed Vaccine Research Oct. 23, 2020 Rajesh Khanna and Aubin Moutal, researchers in the University of Arizona's Department of Pharmacology at the College of Medicine - Tucson, write that new research shows that neuropilin-1 is an independent doorway for the COVID-19 virus to infect cells. This discovery provides insights that may reveal ways to block the virus. The Conversation
Eczema Awareness Month Highlights Condition's Burden Oct. 23, 2020 October, recognized as Eczema Awareness Month, is dedicated to informing those affected and their families, as well as spreading information regarding the condition to the general public. Dr. Vivian Shi, an associate professor of dermatology at the University of Arizona College of Medicine - Tucson, is interviewed about what patients and providers should know about eczema. Healio
Mt. Graham Moving Closer to Critical Access Hospital Designation Oct. 23, 2020 Gila Valley residents could soon see expanded cardiology, wound care and inpatient dialysis services if things go as planned for Mt. Graham Regional Medical Center. The hospital is taking the final steps necessary to be designated a critical access hospital, which would allow it to be reimbursed differently by Medicare and Medicaid. Jill Bullock from the University of Arizona Center for Rural Health, which is helping the hospital during the process, spoke to people at a public meeting on Thursday night. Eastern Arizona Courier
Children’s Cleft Lip and Palate Specialist Joins UArizona College of Medicine – Tucson, Banner – University Medicine Oct. 22, 2020 With UArizona faculty appointments in the Departments of Pediatrics and Otolaryngology - Head and Neck Surgery, Dr. Jonathan Skirko will provide clinical care in advanced pediatric ear, nose and throat medicine at Banner Children’s – Diamond Children’s. Read more Image
UArizona Cancer Center Receives $8.5 Million Gift to Establish Ginny L. Clements Breast Cancer Research Institute Oct. 22, 2020 Ginny L. Clements, a breast cancer survivor and longtime supporter of the University of Arizona has given $8.5 million to the University of Arizona Cancer Center to strengthen the center's breast cancer patient care and research programs. BizTucson
Phoenix Bar Prepares to Begin Karaoke Again Oct. 22, 2020 Kobalt Bar in Phoenix will soon host karaoke nights with new safety protocols in place. "We know that singing, you know, amplifies the spread because it really gets a lot of those viral particles out there into the air and spreads it out," said Dr. Sahd Marvasti, director of public health, prevention and health promotion with the University of Arizona College of Medicine – Phoenix. "If there's a way they can do it outdoors, that would be even better for public health and safety." KTVK-TV (Arizona's Family) Phoenix
What We Know so Far About How COVID Affects the Nervous System Oct. 22, 2020 SARS-CoV-2, the virus that causes COVID-19, can relieve pain, according to a new study by University of Arizona Health Sciences researchers. The finding may explain why nearly half of all people who get COVID-19 experience few or no symptoms, even though they are able to spread the disease, according to the study's corresponding author Rajesh Khanna, a professor in the College of Medicine – Tucson's Department of Pharmacology. Scientific American
Leaving Women out of Study Populations Can Cause ‘Great Harm’ Oct. 22, 2020 In October 2019, the FDA approved emtricitabine/tenofovir alafenamide (FTC/TAF) as a second option for HIV PrEP in at-risk adults and adolescents but excluded cisgender women from the approval because of a lack of efficacy data. The FTC/TAF decision underscored existing concerns over leaving women out of clinical research. “There are sex differences in immune responses, drug metabolism and disease states. Some differences are mediated by hormonal differences and others by other biological factors,” said Infectious Disease News Editorial Board Member Elizabeth Connick, MD, professor of medicine and chief of the division of infectious diseases at the University of Arizona College of Medicine. Healio